A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities (AHEAD2)
Hypertension

About this trial
This is an interventional screening trial for Hypertension focused on measuring emergency department, stage 2 hypertension, minorities
Eligibility Criteria
Inclusion Criteria:
- Stage 2 Hypertension- Elevated BP of ≥160/100 at time of discharge from ED
- Verbal fluency in English or Spanish
- Age 30 to 64 years
Exclusion Criteria:
- Unable to verbalize comprehension of study or impaired decision making (e.g., dementia)
- History of heart failure, myocardial infarction, or stroke
- Lives outside Chicago communities
- Plans to move from Chicago area within the next year
- Pregnant or trying to get pregnant
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Active Comparator
Active Comparator
Usual Care
ED SBIRT-HTN
E SBIRT-HTN + PACTH-c
The Usual Care group arm will received pre-printed discharge instructions and an outpatient referral. (This group represents standard of care.)
The ED SBIRT-HTN (The Emergency Department Screening Brief Intervention and Referral for Treatment) arm consists of a series of risk assessment tools (surveys, video, and noninvasive bedside assessments) designed to be efficient, patient-centered and educational for participants in an emergency department setting. Through the intervention, participants will learn more about hypertension management and complications associated with uncontrolled BP. Participants in the ED-SBIRT-HTN group will receive the following interventions: 1) screening (risk assessment/stratification), 2) a limited bedside echocardiogram (looking for evidence of subclinical cardiac disease), and 3) a urine microalbumin test (marker of early cardiovascular disease).
Participants randomized to the SBIRT-HTN +PACHT-c (Post-Acute Care Hypertension Transition Clinic) arm will receive all interventions of the ED SBIRT-HTN arm plus a 48-72 hour follow-up in the Post-Acute Care Hypertension Transition Clinic for repeat blood pressure assessment, review of screening assessments, and secured PCP appointment with a federally qualified health center within the study site's health system.